Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150162> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q64150162 description "clinical trial" @default.
- Q64150162 description "ensayu clínicu" @default.
- Q64150162 description "klinisch onderzoek" @default.
- Q64150162 description "клінічне випробування" @default.
- Q64150162 name "Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin" @default.
- Q64150162 type Item @default.
- Q64150162 label "Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin" @default.
- Q64150162 prefLabel "Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin" @default.
- Q64150162 P1050 Q64150162-04179D23-7DDC-4508-8197-3325704641C0 @default.
- Q64150162 P1132 Q64150162-997DEB45-2834-4D23-B06E-1B5B183EB666 @default.
- Q64150162 P1476 Q64150162-B85C89EA-D9B2-413E-B14C-6CC5E88FF71D @default.
- Q64150162 P17 Q64150162-49F7A81F-08FA-4DA9-B266-45506D92B3A9 @default.
- Q64150162 P17 Q64150162-8B480D8F-1E12-4872-B7CD-D2202993A553 @default.
- Q64150162 P17 Q64150162-B17A730D-C346-4B3D-9CE1-97AC79D4D416 @default.
- Q64150162 P17 Q64150162-D3E29541-E6B6-4915-8693-5B0E8187DE36 @default.
- Q64150162 P17 Q64150162-E20349CA-80AC-4889-939D-59C38535EC07 @default.
- Q64150162 P1813 Q64150162-8D4FD72D-3155-466D-BCCF-9F4961DAB654 @default.
- Q64150162 P2899 Q64150162-7592BAF6-5362-49E2-BA16-53DE1EAD4A78 @default.
- Q64150162 P3098 Q64150162-78E6AE20-5348-4E9F-9C0C-58A37639E600 @default.
- Q64150162 P31 Q64150162-8C5D6A68-94C5-448D-A676-85AE51EF7A83 @default.
- Q64150162 P4844 Q64150162-042CAD4A-80CB-4839-A939-EB400511149F @default.
- Q64150162 P4844 Q64150162-8D0C7CDF-5A32-4439-B69B-9E86E94B6661 @default.
- Q64150162 P580 Q64150162-CC5EC768-0407-431E-9834-9A03369F4D91 @default.
- Q64150162 P582 Q64150162-81040202-97A2-4D95-941D-D77E783DC73B @default.
- Q64150162 P6099 Q64150162-1212D678-4BE8-4489-B4B6-7252ECCC53DB @default.
- Q64150162 P6099 Q64150162-526E875C-9AE9-4DDA-B62F-9DAAF17A8083 @default.
- Q64150162 P6153 Q64150162-1C90BA96-AF20-4BE5-93DA-21AFCB3DABEE @default.
- Q64150162 P6153 Q64150162-3665DD4C-D33B-4650-BA06-700AEFDB304D @default.
- Q64150162 P6153 Q64150162-3C64BAF0-6172-48C9-84BA-420013494E58 @default.
- Q64150162 P6153 Q64150162-71422C51-A544-42AA-B52C-03E492C80E32 @default.
- Q64150162 P6153 Q64150162-7DD8523A-5981-45A6-B604-37D0D8EA88D3 @default.
- Q64150162 P6153 Q64150162-9693401E-5C8D-4378-A341-54FE15A48B4B @default.
- Q64150162 P6153 Q64150162-973BFDFD-6AAF-4C2C-9149-22FB709033C8 @default.
- Q64150162 P6153 Q64150162-AC0FF02B-0772-4CFA-A3C5-1B6B69C4226F @default.
- Q64150162 P6153 Q64150162-AD069472-FAFE-453C-8442-DE6BB172CC9C @default.
- Q64150162 P6153 Q64150162-AE014592-4567-4C5F-88D0-BC2A37EDBA20 @default.
- Q64150162 P6153 Q64150162-B2586111-4B93-4784-BAFB-E38702BA4FE0 @default.
- Q64150162 P6153 Q64150162-C9ECA7E0-C9F2-4CEC-B592-ACBCE3982769 @default.
- Q64150162 P6153 Q64150162-D43C9549-8FB3-489F-A2E7-47EE3C156B13 @default.
- Q64150162 P6153 Q64150162-D84D80CD-D0BF-4E7E-A0B8-357442806D1D @default.
- Q64150162 P6153 Q64150162-E38C59AD-960C-49E5-814F-5AFC205A05B7 @default.
- Q64150162 P6153 Q64150162-F83973EC-D2D5-47B4-BB17-BCBFFA206979 @default.
- Q64150162 P8363 Q64150162-74F7B2CD-FE32-41F1-B3E4-EA7FEBEA8149 @default.
- Q64150162 P1050 Q1077603 @default.
- Q64150162 P1132 "+386" @default.
- Q64150162 P1476 "Randomized, Double-Blind, Phase 2/3 Study in Subjects With Malignant Pleural Mesothelioma With Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ATOMIC-Meso Phase 2/3 Study)" @default.
- Q64150162 P17 Q145 @default.
- Q64150162 P17 Q30 @default.
- Q64150162 P17 Q38 @default.
- Q64150162 P17 Q408 @default.
- Q64150162 P17 Q865 @default.
- Q64150162 P1813 "ATOMIC" @default.
- Q64150162 P2899 "+18" @default.
- Q64150162 P3098 "NCT02709512" @default.
- Q64150162 P31 Q30612 @default.
- Q64150162 P4844 Q412415 @default.
- Q64150162 P4844 Q415220 @default.
- Q64150162 P580 "2017-08-01T00:00:00Z" @default.
- Q64150162 P582 "2020-10-01T00:00:00Z" @default.
- Q64150162 P6099 Q42824440 @default.
- Q64150162 P6099 Q42824827 @default.
- Q64150162 P6153 Q1130172 @default.
- Q64150162 P6153 Q131252 @default.
- Q64150162 P6153 Q1418766 @default.
- Q64150162 P6153 Q15901822 @default.
- Q64150162 P6153 Q164946 @default.
- Q64150162 P6153 Q1808012 @default.
- Q64150162 P6153 Q25188472 @default.
- Q64150162 P6153 Q30279623 @default.
- Q64150162 P6153 Q30282252 @default.
- Q64150162 P6153 Q3747180 @default.
- Q64150162 P6153 Q50379732 @default.
- Q64150162 P6153 Q6747552 @default.
- Q64150162 P6153 Q700801 @default.
- Q64150162 P6153 Q74543361 @default.
- Q64150162 P6153 Q7526207 @default.
- Q64150162 P6153 Q7569131 @default.
- Q64150162 P8363 Q78089383 @default.